Bharat Immunological & Biological Corporation Ltd

As of 31-Oct, Bharat Immunological & Biological Corporation Ltd's stock price is declining at 20.28, down 1.51%, and has underperformed its sector and the benchmark Sensex significantly. The stock is on a bearish trend, trading below all major moving averages, with a year-to-date decline of 14.75% despite increased investor participation.

As of 24-Sep, Bharat Immunological & Biological Corporation Ltd's stock is at 21.54, down 0.23%, and has declined 1.96% over the last three days. The company faces significant challenges, including a drastic drop in net sales, high debt, and underperformance compared to market benchmarks, indicating a risky investment outlook.

As of 23-Sep, Bharat Immunological & Biological Corporation Ltd's stock price is at 21.59, down 0.83%, and has underperformed the market with a total decline of 4.60% over the past month. The stock is trading below all key moving averages, indicating a bearish trend and decreased investor participation.

As of 22-Sep, Bharat Immunological & Biological Corporation Ltd is facing a decline in stock price at 21.77, with a short-term underperformance reflected in negative returns and trading below key moving averages. Despite a significant increase in delivery volume, the stock lags behind the broader market, which has shown positive momentum.

As of 19-Sep, Bharat Immunological & Biological Corporation Ltd is priced at 22.01, showing a slight increase but trading below all moving averages, indicating a bearish trend. The stock has underperformed significantly over longer periods, with a year-to-date decline of 7.48%, driven by weak fundamentals and declining investor interest.

As of 18-Sep, Bharat Immunological & Biological Corporation Ltd's stock price is declining at 21.92, down 0.36%, and has underperformed its sector. The stock has dropped 24.98% over the past year and is trading below all major moving averages, indicating a bearish trend despite increased trading activity.

As of 17-Sep, Bharat Immunological & Biological Corporation Ltd's stock price is 22.00, down 0.59%. The stock has underperformed its sector and benchmark indices, showing weak fundamentals and a lack of recent financial disclosures, which has led to low investor confidence.

As of 16-Sep, Bharat Immunological & Biological Corporation Ltd is priced at 22.13, showing a slight increase but underperforming against the Sensex and exhibiting weak long-term fundamentals. Despite a recent uptick, declining sales and high debt raise concerns about its investment viability.

As of 15-Sep, Bharat Immunological & Biological Corporation Ltd is experiencing a decline in its stock price, currently at 21.97, reflecting a bearish trend with significant drops in investor participation and underperformance compared to the benchmark Sensex. The stock has fallen 7.65% year-to-date, contrasting sharply with the Sensex's gain of 4.67%.

As of 12-Sep, Bharat Immunological & Biological Corporation Ltd's stock is at 22.00, down -0.81%, and has significantly underperformed its sector and the Sensex. The company faces weak fundamentals, declining sales, and a high debt-to-EBITDA ratio, indicating a challenging outlook and low investor confidence.

As of 11-Sep, Bharat Immunological & Biological Corporation Ltd's stock price is at 22.18, showing a slight recovery today after a decline, but it has significantly underperformed over the past year and longer periods compared to the market. Despite a short-term gain, investor participation has dropped notably, indicating ongoing challenges for the company.